Publications

BibTex format

@article{Gall:2019:10.18632/oncotarget.26511,
author = {Gall, TMH and Gerrard, G and Frampton, AE and Castellano, L and Ahmad, R and Habib, N and Spalding, D and Pai, M and Foroni, L and Jiao, LR},
doi = {10.18632/oncotarget.26511},
journal = {Oncotarget},
pages = {696--706},
title = {Can we predict long-term survival in resectable pancreatic ductal adenocarcinoma?},
url = {http://dx.doi.org/10.18632/oncotarget.26511},
volume = {10},
year = {2019}
}

Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Objective: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive tumour associated with poor 5-year survival. We aimed to determine factors which differentiate short and long-term survivors and identify a prognostic biomarker. Methods: Over a ten-year period, patients with resected PDAC who developed disease recurrence within 12 months (Group I) and those who had no disease recurrence for 24 months (Group II) were identified. Clinicopathological data was analysed. Ion Torrent high-throughput sequencing on DNA extracted from FFPE tumour samples was used to identify mutations. Additionally, peripheral blood samples were analysed for variants in cell-free DNA, circulating tumour cells (CTCs), and microRNAs. Results: Multivariable analysis of clinicopathological factors showed that a positive medial resection margin was significantly associated with short disease-free survival (p = 0.007). Group I patients (n = 21) had a higher frequency of the KRAS mutant mean variant allele (16.93% ± 11.04) compared to those in Group II (n = 13; 7.55% ± 5.76, p = 0.0078). Group I patients also trended towards having a KRAS c.35G>A p.Gly12Asp mutation in addition to variants in other genes, such as TP53, CDKN2A, and SMAD4. Mutational status of cell-free DNA, and number of CTCs, was not found to be useful in this study. A circulating miRNA (hsa-miR-548ah-5p) was found to be significantly differentially expressed. Conclusions: Medial resection margin status and the frequency of KRAS mutation in the tumour tissue are independent prognostic indicators for resectable PDAC. Circulating miRNA hsa-miR-548ah-5p has the potential to be used as a prognostic biomarker.
AU  - Gall,TMH
AU  - Gerrard,G
AU  - Frampton,AE
AU  - Castellano,L
AU  - Ahmad,R
AU  - Habib,N
AU  - Spalding,D
AU  - Pai,M
AU  - Foroni,L
AU  - Jiao,LR
DO  - 10.18632/oncotarget.26511
EP  - 706
PY  - 2019///
SN  - 1949-2553
SP  - 696
TI  - Can we predict long-term survival in resectable pancreatic ductal adenocarcinoma?
T2  - Oncotarget
UR  - http://dx.doi.org/10.18632/oncotarget.26511
UR  - https://www.ncbi.nlm.nih.gov/pubmed/30774772
UR  - http://hdl.handle.net/10044/1/67334
VL  - 10
ER  -

Download

DrAdamFrampton

Contact

Location

Summary

Citation

BibTex format

RIS format (EndNote, RefMan)